M. Germani

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
M A Germani, M. M. Germani, M. A. Germani, M Germani, Massimiliano Germani, M. Germani
Publication record
46 papers · 1,097 citations · H-index 13

PAPERS

Population pharmacokinetic–pharmacodynamic analysis of givinostat
20235 citationsauthor #2
Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α‐Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease
202244 citationsauthor #8
An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models
202156 citationsauthor #52
Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents
20215 citationsauthor #52
Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach
202021 citationsauthor #5
TRAITEMENT D'UNE INFECTION À VRS
20170 citationsauthor #4
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight
20140 citationsauthor #3
Cancer Therapy : Preclinical NMS-E 973 , a Novel Synthetic Inhibitor of Hsp 90 with Activity against Multiple Models of Drug Resistance to Targeted Agents , Including Intracranial Metastases
20130 citationsauthor #9
A predictive pharmacokinetic–pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination
201338 citationsauthor #2
NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases
201327 citationsauthor #9
Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat
2013145 citationsauthor #4
Predictive pharmacokinetic–pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts
201339 citationsauthor #2
Structure of HSP90 with NMS-E973 inhibitor bound
20130 citationsauthor #9
A4S: A user-friendly graphical tool for pharmacokinetic and pharmacodynamic (PK/PD) simulation
201313 citationsauthor #1
A Minimal Model of Tumor Growth Inhibition in Combination Regimens Under the Hypothesis of No Interaction Between Drugs
20128 citationsauthor #4
457 In vitro and in vivo tools to assess the myelotoxicity of anti-cancer drugs
20100 citationsauthor #2
Testing additivity of anticancer agents in pre-clinical studies: a PK/PD modelling approach.
200940 citationsauthor #3
A model-based approach to the in vitro evaluation of anticancer activity
200924 citationsauthor #2
Re: Antitumor Efficacy Testing in Rodents. Author's reply
20093 citationsauthor #3
Re: Antitumor efficacy testing in rodents.
20096 citationsauthor #3
Nonparametric Modeling and Population Approach to the Individualized Heart Rate Correction of the QT Interval
20080 citationsauthor #1
A Minimal Model of Tumor Growth Inhibition
200830 citationsauthor #2
Evaluation of a basic physiologically based pharmacokinetic model for simulating the first-time-in-animal study.
200731 citationsauthor #1
We-P11:107 Metabolic syndrome: Evaluation of response to metformin, diet and physical activity
20060 citationsauthor #5
A minimal model describing the effect of drug administration on tumor growth dynamics
20062 citationsauthor #4
Computational Models Supporting Lead Optimization in Drug Discovery
20060 citationsauthor #3
A pharmacokinetic-pharmacodynamic model for predicting tumour growth inhibition in mice: a useful tool in oncology drug development.
200530 citationsauthor #3
Evaluation of a physiologically-based pharmacokinetic approach for simulating the first-time-in-animal study.
200510 citationsauthor #1
Population modeling of tumor growth inhibition in vivo: application to anticancer drug development
20046 citationsauthor #3
PK/PD modeling of tumor growth inhibition in vivo
20040 citationsauthor #5
113 Pharmacokinetic-pharmacodynamic (PK-PD) modeling of tumor growth inhibition in mice: the activity of brostallicin is enhanced in cells with high glutathione-S-transferase
20040 citationsauthor #1
A PK-PD model for predicting tumor growth inhibition in mice: a useful tool in oncology drug development
20043 citationsauthor #3
Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents
2004481 citationsauthor #7
Population modeling of tumor growth in untreated xenografted mice
20043 citationsauthor #3
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time
20038 citationsauthor #1
A Bayesian approach to non-parametric AUC estimation in population studies
20030 citationsauthor #5
[Headache: new epidemiologic and nosographic trends].
19941 citationsauthor #1
[Hemicrania: comparison of physiopathogenetic theories].
19941 citationsauthor #1
A 23Na-NMR study on cation transport systems in a patient with hypokalemic periodic paralysis.
19931 citationsauthor #4
[The nonspecific bronchial stimulation test with methacholine and an ultrasonic mist of distilled water: which is to be preferred in the military sphere?].
19920 citationsauthor #3
[Ciprofloxacin: a new fluoroquinolone for the treatment of respiratory tract infections].
19910 citationsauthor #2
Aggressive Granulomatosis Lesions after Hip Arthroplasty. Revision Arthroplasty with Bias Total Hip System (5 Cases)
19910 citationsauthor #2
Plasma thiobarbituric acid reactive substances a predictive marker of cerebral ischemia in patients at high risk?
19919 citationsauthor #2
[Effects of active postural inhibition on circulating levels of atrial natriuretic peptide in young hypertensive and normotensive subjects in the presence or absence of positive family history of essential arterial hypertension].
19900 citationsauthor #4
Blood lipid peroxides in TIA: relation to platelet function and metabolic profile
19899 citationsauthor #4
[Echographic diagnosis of diffused liver diseases: histologic correlations].
19870 citationsauthor #4

TIMELINE

1987 0 citations

1989 9 citations

1990 0 citations

1991 9 citations

1992 0 citations

1993 1 citations

1994 2 citations

2003 8 citations

2004 493 citations

2005 40 citations

2006 2 citations

2007 31 citations

2008 30 citations

2009 73 citations

2010 0 citations

2012 8 citations

2013 262 citations

2014 0 citations

2017 0 citations

2020 21 citations

2021 61 citations

2022 44 citations

2023 5 citations

M. Germani

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT